The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Omnexel, 400 micrograms, prolonged release tablets, film-coated

400 microgram(s) Prolonged-release tablet

Imbat LimitedPPA1151/020/001

Main Information

Trade NameOmnexel, 400 micrograms, prolonged release tablets, film-coated
Active SubstancesTamsulosin hydrochloride
Strength400 microgram(s)
Dosage FormProlonged-release tablet
Licence HolderImbat Limited
Licence NumberPPA1151/020/001

Group Information

ATC CodeG04CA Alpha-adrenoreceptor antagonists
G04CA02 tamsulosin

Status

Authorised/WithdrawnAuthorised
Licence Issued14/09/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0024-066-024
Interchangeable List DocumentPDF of Interchangeable List
« Back